NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Immunicon Corporation


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Global Nanomagnetics Strategic Business Report Analyses the Worldwide Market in Terms of US$ Millions
2009 FEB 17 ... Technologies, Inc, Hitachi Metals, Ltd, IBM Corp, IBM Research Centers Nanoscience, Immunicon Corporation, Liquids Research Ltd, MACH we Inc, Magforce Nanotechnologies Gmbh, MAGNETEC GmbH, ...
Subject: Research and Markets
Price: $3.00
*
Immunicon Corporation Announces Availability of Fluorescence In-Situ Hybridization Product Portfolio
2008 APR 21 ... Immunicon Corporation (NASDAQ:IMMC) announced the availability of a new product portfolio for Fluorescence ...
Subject: Immunicon Corporation
Price: $3.00
*
Immunicon Corporation Announces Corporate Restructuring
2008 MAR 24 ... Immunicon Corporation (NASDAQ:IMMC) announced it has reduced staff levels and incurred certain expenses in ...
Subject: Immunicon Corporation
Price: $3.00
*
Immunicon Corporation Announces FDA Clearance of the CellSearch(TM) Circulating Tumor Cell Kit for Monitoring Patients with Metastatic Prostate Cancer
2008 MAR 10 ... Immunicon Corporation (NASDAQ:IMMC) announced that the FDA has cleared the CellSearch(TM) Circulating Tumor ...
Subject: Prostate Cancer
Price: $3.00
*
Immunicon Corporation Announces Receipt of Notice from Nasdaq
2008 FEB 11 ... Immunicon Corporation (NASDAQ-GM:IMMC) announced that, on January 23, 2008, it received a notice from The ...
Subject: Immunicon Corporation
Price: $3.00
*
Immunicon Corporation Announces Receipt of Notice from NASDAQ and ''Going Concern'' Opinion
2008 APR 21 ... Immunicon Corporation (NASDAQ-GM:IMMC) announced that, on April 2, 2008, it received a notice from The NASDAQ ...
Subject: Immunicon Corporation
Price: $3.00
*
Immunicon Corporation Completes Sale
2008 AUG 18 ... Immunicon Corporation (OTCBB:IMMC.OB) announced that Immunicon Corporation ...
Subject: Immunicon Corporation
Price: $3.00
*
Immunicon Corporation is Considering Strategic Alternatives
2008 APR 21 ... Immunicon Corporation (NASDAQ:IMMC) announced that it is exploring and evaluating various financial and ...
Subject: Immunicon Corporation
Price: $3.00
*
Immunicon Corporation Receives Grant to Develop Test for Residual Disease in Leukemia Patients
2008 MAY 5 ... Immunicon Corporation (NASDAQ CM:IMMC) announced that the company received a four-year grant from the Center ...
Subject: Leukemia
Price: $3.00
*
Immunicon Corporation to Introduce Repeat-Free(TM) Poseidon(TM) FISH Probes and Present Workshop and Posters at 2008 AACR Annual Meeting
2008 APR 21 ... Immunicon Corporation (NASDAQ-GM:IMMC) will introduce its portfolio of Repeat-Free(TM) Poseidon(TM) FISH ...
Subject: Immunicon Corporation
Price: $3.00
*
Immunicon Corporation to Present at 2008 ASCO Annual Meeting
2008 JUN 16 ... The Circulating Tumor Cell technology developed by Immunicon Corporation (OTCBB:IMMC) will be the subject of 12 abstracts presented in a variety of applications ...
Subject: Immunicon Corporation
Price: $3.00
*
Immunicon Files for Strategic Restructuring
2008 JUN 23 ... Immunicon Corporation (OTC BB:IMMC.OB) announced that it and its wholly-owned subsidiaries filed voluntary ...
Subject: Immunicon Corporation
Price: $3.00
*
Veridex Announces Agreement to Acquire the Assets of Immunicon Corporation
2008 JUN 23 ... it has signed an asset purchase agreement to acquire substantially all of the assets of Immunicon Corporation (BULLETIN BOARD: IMMC) for $31 million in cash subject to certain closing date ...
Subject: Veridex, Llc
Price: $3.00
*
Veridex Completes Acquisition of Immunicon Corporation Assets
2008 AUG 18 ... has completed its previously announced acquisition of substantially all of the assets of Immunicon Corporation and its wholly-owned subsidiaries. The assets acquired include ...
Subject: Cancer
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login